Trial
NCT06235242
GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Grit Biotechnology
Collaborators
—
Condition
Adult
Intervention
GT201 injection in combination with teraplizumab injection
Why stopped
The study was terminated from a business perspective.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-27